News from the FDA/CDC
News from the FDA/CDC
Twin births down among women 30 and older
Race and ethnicity also played a role in the decline in twin birthrates since 2014.
News
FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinoma
The approval is based on positive results from the KEYNOTE-146 trial.
News from the FDA/CDC
U.S. infant mortality continued slow decline in 2017
Massachusetts had the nation’s lowest rate; Mississippi had the highest.
News
HHS proposes pathways for drug importation
Officials at the U.S. Department of Health and Human Services have announced a new plan that they say would lay the foundation for safe...
News
Lymphoma risk prompts FDA recall of Allergan’s textured breast implants
The FDA asked Allergan to recall six brands of textured breast implants and expanders because of the lymphoma risk they pose.
News from the FDA/CDC
Long-term trend: Women receiving fewer pelvic exams
Data for women aged 15-44 “could provide a benchmark for estimates of the prevalence” before ACOG updated its guidelines in 2018.
News
FDA approves bevacizumab-bvzr for several cancers
The bevacizumab biosimilar is now approved for metastatic colorectal cancer, advanced non-squamous non–small cell lung cancer, recurrent...
News from the FDA/CDC
ACIP extends HPV vaccine coverage
Committee voted for catch-up vaccination for all individuals through age 26 years, optional for older adults.
News from the FDA/CDC
Physical activity prevalence shows urban/rural divide
More Americans are exercising, but “participation in physical activity remains a public health concern,” the CDC says.
News
FDA approves trastuzumab-anns for HER2-positive breast, gastric cancer
This is the fifth FDA approval of a trastuzumab biosimilar.
News
FDA approves PI3K inhibitor alpelisib for breast cancer
The PI3K inhibitor is approved for use with fulvestrant for HR-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer in...